GILD
Stock Details
GILD is Gilead Sciences, Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 82.37$. Average daily volumn in 3 months 6.24M. Market cap 101.04B
Stock symbol : GILD. Exchange : NasdaqGS. Currency : USD Lastest price : 80.90$. Total volume : 1.30M. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Gilead Sciences, Inc. (GILD)
Last Price
80.90$Change
1.32Volume
1.30M
| Previous Close | 79.58 |
| Open | 79.96 |
| Day Range | 79.79-80.94 |
| Bid | 80.82 x 800 |
| Ask | 80.83 x 1k |
| Volume | 1.3M |
| Average Volume | 6.24M |
| Market Cap | 101.04B |
| Beta | 0.40 |
| 52 Week Range | 57.17-89.74 |
| Trailing P/E | 22.23 |
| Foward P/E | 11.21 |
| Dividend (Yield %) | 3.77% |
| Ex-Dividend Date | 2023-03-14 |
Financial Details
Organization
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of vi... ral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Market Cap:
101.04BRevenue:
27.28BTotal Assets:
63.17BTotal Cash:
5.41B
News about "Gilead Sciences, Inc."
Gilead Sciences Inc. (GILD) Stock: What the Analysts are Saying
Source from : newsheater - 5 days ago
Gilead Sciences Inc. (NASDAQ: GILD) has a price-to-earnings ratio that is above its average at 21.65x. and a 36-month beta value of 0.40. Opinions on the stock are mixed, with 9 analysts rating it as ...See details»
gilead sciences inc.
Source from : Fox Business - 5 days ago
Pfizer and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG are racing to produce the first antiviral pill that people could take at early signs of the ...See details»
Gilead (GILD) Exercises Option to License Nurix's Candidate
Source from : YAHOO!Finance - 7 days ago
Gilead (GILD) exercises an option under its collaboration agreement with Nurix to license the latter???s investigational targeted protein degrader molecule NX 0479.See details»
Gilead Sciences Inc. stock rises Thursday, still underperforms market
Source from : MarketWatch - 12 days ago
Shares of Gilead Sciences Inc. inched 0.25% higher to $79.85 Thursday, on what proved to be an all-around great trading session for the stock market, ...See details»
Gilead Sciences Inc. (GILD) Has Recovered 26.05% From Its Low: Is This The Beginning Of A Trend?
Source from : stocksregister - 11 days ago
Gilead Sciences Inc. (NASDAQ:GILD) price on Friday, March 17, fall -3.18% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $77.31. A look at the stock’s ...See details»
Gilead Sciences Inc. (GILD) Stock: A Guide to the Market Trend
Source from : newsheater - 7 days ago
The stock of Gilead Sciences Inc. (GILD) has seen a -0.06% decrease in the past week, with a -4.71% drop in the past month, and a -8.22% decrease in the past quarter. The volatility ratio for the week ...See details»
Gilead Sciences, Inc. (NASDAQ:GILD) is a favorite amongst institutional investors who own 84%
Source from : Yahoo Finance - 16 days ago
We note that hedge funds don't have a meaningful investment in Gilead Sciences. BlackRock, Inc. is currently the company's largest shareholder with 11% of shares outstanding. For context ...See details»
Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities
Source from : Stockhouse - 6 days ago
s Zeroing In™: Ending the HIV Epidemic Grant Program – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $3 million in grant funding to eight organizations to provide ...See details»
Gilead Sciences must pay $1.8 million in attorney fees and costs after denying shareholders access to records
Source from : Courthouse News Service - 1 year ago
The Gilead Sciences headquarters in Foster City, Calif., in April 2020. (AP Photo/Ben Margot, File) (CN) — A Delaware court on Thursday ordered Gilead Sciences Inc. to pay nearly $1.8 million in ...See details»
Gilead Presents New Data From HIV Cure Research Program and Collaborations Exploring Novel Investigational Combinations and Strategies
Source from : Stockhouse - 1 month ago
Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from four collaborative studies evaluating novel investigational combinations and strategies with the potential to target the HIV viral ...See details»
Gilead Sciences, Inc.
Source from : Fierce Healthcare - 1 month ago
For 35 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research. Gilead researchers have developed 12 HIV medications ...See details»
Gilead Sciences Inc. stock rises Tuesday, still underperforms market
Source from : MarketWatch - 13 days ago
Shares of Gilead Sciences Inc. GILD rallied 1.28% to $79.77 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.68% to 3,920 ...See details»
Gilead Sciences Inc
Source from : Reuters - 13 days ago
2023 Future of Healthcategory GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill, article with image February 22, 2023 Worldcategory Britain's NICE to speed ...See details»
GILD Gilead Sciences, Inc.
Source from : Seeking Alpha - 5 days ago
**NM signifies a non meaningful value. A dash signifies the data is not available.See details»